Hypercalcaemia, renal dysfunction, anaemia and bone lesions (CRAB) do not always represent multiple myeloma: diffuse large B cell lymphoma presenting with CRAB symptoms in a 69-year-old man.

BMJ Case Reports
Hafez Mohammad Ammar AbdullahTony Oliver

Abstract

Hypercalcaemia, renal dysfunction, anaemia and bone lesions (CRAB) are a constellation of signs and symptoms that are collectively referred to as the CRAB features. When present together, multiple myeloma (MM) should be at the top of the differential diagnosis. We present a 69-year-old man who presented with severe body aches and bone pain in his ribs and pelvis, associated with fatigue and constipation. He was found to have hypercalcaemia, acute kidney injury, anaemia and numerous lytic lesion on chest imaging. Physical examination and imaging were unremarkable for any enlarged lymph nodes. The patient was initially suspected to have multiple myeloma, however, serum and urine protein electrophoresis, and serum free light chain assays were negative. The patient was ultimately diagnosed with diffuse large B cell lymphoma based on a bone marrow biopsy. This case highlights the fact that presence of hypercalcaemia, renal dysfunction, anaemia and bone lesions are not usually specific for MM.

References

Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Dec 10, 1999·American Journal of Clinical Pathology·S IravaniB Schnitzer
Dec 29, 1999·International Journal of Radiation Oncology, Biology, Physics·P FidiasD C Harmon
Aug 14, 2002·Journal of Surgical Oncology·Agustin AvilésJudith Huerta-Guzmán
Apr 16, 2004·The New England Journal of Medicine·G David Roodman
Apr 23, 2004·Leukemia & Lymphoma·Yoshiko MatsuhashiToshihiko Ishida
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hironobu ShibataToshio Matsumoto
Sep 10, 2005·Blood·Lindsay M MortonMartha S Linet
Oct 11, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lynn R GoldinMartha S Linet
May 9, 2006·American Journal of Hematology·Hirotaka TakasakiYoshiaki Ishigatsubo
May 11, 2006·International Journal of Oncology·J M HorsmanB W Hancock
Dec 12, 2007·Best Practice & Research. Clinical Haematology·Flavia R Esteve, G David Roodman
Jan 23, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R BettiniM Falconi
May 15, 2009·British Journal of Haematology·Lynn R GoldinOla Landgren
Dec 4, 2010·Blood Reviews·Meletios-Athanassios Dimopoulos, Evangelos Terpos
Mar 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnRandy D Gascoyne
Mar 8, 2014·BMJ Case Reports·Sanjay Kumar MandalSoumya Sarathi Mondal
Mar 19, 2014·International Journal of Cancer. Journal International Du Cancer·Marina T van LeeuwenClaire M Vajdic
Aug 20, 2014·British Journal of Haematology·Graham W SlackRandy D Gascoyne
Dec 3, 2014·The Lancet Oncology·S Vincent RajkumarJesus F San Miguel

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.